Suppr超能文献

持续的胃酸抑制是幽门螺杆菌诊断中的一个混杂因素。

Ongoing gastric acid inhibition is a confounding factor in Helicobacter pylori diagnosis.

作者信息

Jonkers D, Houben P, Stobberingh E, Stockbrügger R

机构信息

Department of Gastroenterology, University Hospital Maastricht, University of Limburg, The Netherlands.

出版信息

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):49-53. doi: 10.1097/00042737-199701000-00013.

Abstract

BACKGROUND

Eradication of Helicobacter pylori by antibiotics in combination with gastric acid inhibition can result in overgrowth of non-H. pylori bacterial flora. This may confound the histological detection of H. pylori at eradication control if non-specific staining methods are used.

OBJECTIVE AND METHODS

In 18 patients treated with amoxycillin (2 weeks) and omeprazole (6 weeks), endoscopically obtained gastric juice was cultured and two biopsies of corpus, antrum and duodenum were taken before and after eradication therapy (with gastric acid inhibition still going on) for culture and for histology to assess the intragastric bacterial flora. By histology, modified Giemsa (MG) and an H. pylori-specific immunohistochemical stain (IMM) were evaluated.

RESULTS

Median pH of gastric juice was 1.5 (n = 18) before and 7 (n = 17) after eradication therapy, when patients were still on omeprazole. After therapy, culture showed a significant decrease (P < 0.05) in mean amount of H. pylori in corpus, antral and duodenal biopsies and a significant increase of non-H. pylori flora (P < 0.05) in gastric juice, corpus, antral and duodenal mucosa. With culture as a standard, 16 and 4 biopsy specimens were scored falsely positive for H. pylori by MG and IMM, respectively, and H. pylori was not detected in 23 and 13 biopsy specimens when culture was H. pylori-positive.

CONCLUSION

Because of the possible presence of non-H. pylori flora after eradication therapy, the use of IMM is recommended in this situation for the histological detection of H. pylori, especially in those patients with ongoing gastric acid inhibitory therapy.

摘要

背景

抗生素联合胃酸抑制药物根除幽门螺杆菌可导致非幽门螺杆菌菌群过度生长。如果使用非特异性染色方法,这可能会在根除控制时混淆幽门螺杆菌的组织学检测。

目的和方法

对18例接受阿莫西林(2周)和奥美拉唑(6周)治疗的患者,在根除治疗前后(胃酸抑制仍在进行),通过内镜获取胃液进行培养,并取胃体、胃窦和十二指肠的两份活检组织进行培养和组织学检查,以评估胃内细菌菌群。通过组织学方法,评估改良吉姆萨染色(MG)和幽门螺杆菌特异性免疫组化染色(IMM)。

结果

根除治疗前胃液中位pH值为1.5(n = 18),治疗后患者仍在服用奥美拉唑时,胃液中位pH值为7(n = 17)。治疗后,培养显示胃体、胃窦和十二指肠活检组织中幽门螺杆菌平均数量显著减少(P < 0.05),胃液、胃体、胃窦和十二指肠黏膜中非幽门螺杆菌菌群显著增加(P < 0.05)。以培养结果为标准,MG和IMM分别将16例和4例活检标本误判为幽门螺杆菌阳性,当培养结果显示幽门螺杆菌阳性时,23例和13例活检标本未检测到幽门螺杆菌。

结论

由于根除治疗后可能存在非幽门螺杆菌菌群,在这种情况下,推荐使用IMM进行幽门螺杆菌的组织学检测,尤其是对于正在接受胃酸抑制治疗的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验